This may not be an actual “physical” disaster averted yet because we don’t know the long-term effects on the people who have taken the ARBs and possibly other medications that were tainted with carcinogens or other “poisons.” When we (health care providers) were first notified of this issue, my first …

Intensive diabetes therapy can be associated with excess weight gain, central obesity, and dyslipidemia with increased heart disease risk.

Addition of bolus insulin to avoid overbasalization is key.

Specific A1c, glucose ranges associated with diabetes-specific vision impairment.

Nancy J. D'Hondt  RPh, CDE, FAADE is a past president of the American Association of Diabetes Educators. She is a staff/clinical pharmacist in a 600-bed facility and is responsible for the review and processing of medication orders, patient-controlled analgesia, ADR and DUR monitoring, pharmacokinetic dosing, anticoagulation, and multidisciplinary rounds. Nancy specializes in diabetes care and self-management support for both the inpatient and outpatient populations, providing expertise on protocol development and implementation, staff education, and formulary decisions.

In this Exclusive Interview, Nancy D'Hondt talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the need for diabetes education and ways to reach people at risk as well as those in need of support.

Lifestyle intervention in pregnancy might reduce adverse effects of maternal obesity on neonatal adiposity.

Recent studies have shown that statins can raise blood sugar and more patients on statin therapy were diagnosed with diabetes mellitus.

Monitoring glucose in midlife may help prevent future cardiovascular disease, according to a study published in Diabetes Care.

Sanofi and Lexicon to continue any required studies in effort to move sotagliflozin forward.